Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-10-10Clinical Trial Update: Transversus Abdominis Plane (TAP) Block After Kidney Transplantation [NA]
A clinical trial evaluating transversus abdominis plane (TAP) block after kidney transplantation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array) [NA]
This clinical trial update indicates that NCT00746057 was terminated; the study evaluated early microarray-based screening for chronic rejec…
-
FDA approval · 2013-09-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech, Inc.
-
FDA approval · 2013-09-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for a generic mycophenolate mofetil product from Strides Pharma Science Limited, enabling its market…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients [Phase 3]
A Phase 3 randomized trial comparing modified-release tacrolimus with mycophenolate mofetil in de novo kidney transplant recipients has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients [Phase 2]
Phase 2 pharmacokinetic study evaluating a modified-release tacrolimus regimen for immunosuppression in stable kidney transplant patients; r…
-
FDA approval · 2013-09-04FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for PROGRAF (tacrolimus) submitted by Astellas Pharma US, Inc. The action relates to an update o…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™.
A completed clinical trial assessed medication adherence in kidney transplant recipients, comparing adherence with and without the Med-O-Whe…
-
CLINICAL_TRIALS research · 2013-09-02Clinical Trial Update: Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
A completed clinical trial investigating noninvasive methods to monitor graft survival in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus [Phase 4]
Phase 4 clinical trial update evaluating everolimus-based strategies for steroid or cyclosporine withdrawal after kidney transplantation.
-
FDA approval · 2013-08-16FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approves a supplemental application for PROGRAF (tacrolimus) filed by Astellas Pharma US, approving changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: IV Insulin Protocol in Diabetes and Renal Transplantation [NA]
A completed clinical trial evaluated an intravenous insulin protocol in people with diabetes undergoing kidney transplantation; results were…
-
FDA approval · 2013-07-19FDA Approved: ASTAGRAF XL — Original Application (Astellas Pharma US, Inc.)
FDA approved ASTAGRAF XL (tacrolimus extended-release capsules) under an Original Application from Astellas Pharma US. It provides a new tac…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation [Phase 1, Phase 2]
Phase 1/2 trial update comparing steroid-free versus steroid-based immunosuppression in pediatric kidney transplant recipients; results have…
-
CLINICAL_TRIALS research · 2013-06-11Clinical Trial Update: Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression [Phase 4]
Phase 4 clinical trial updating on belatacept-based immunosuppression versus standard regimens in kidney transplant patients, with a focus o…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Diet Rich in N-3 Polyunsaturated Fatty Acids in Renal Transplant Recipients [Phase 4]
A Phase 4 clinical trial evaluating a diet rich in omega-3 polyunsaturated fatty acids in renal transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival
This completed clinical trial from NIAID examined how donor and recipient genetic expression influences survival after heart, lung, liver, a…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus [Phase 4]
A Phase 4 pilot trial evaluating whether diet and exercise influence tacrolimus levels in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: GFR Measurement With Contrast-enhanced Dynamic MRI [NA]
This completed clinical trial investigates measuring glomerular filtration rate (GFR) with contrast-enhanced dynamic MRI in kidney transplan…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients [Phase 1]
A Phase 1 pilot study evaluated the safety and efficacy of alefacept in de novo kidney transplant recipients; the trial status is terminated…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF [Phase 4]
A Phase 4 study evaluated the safety and efficacy of ADVAGRAF (tacrolimus modified-release) in kidney transplant patients who had previously…
-
CLINICAL_TRIALS research · 2013-04-18Clinical Trial Update: EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety [Phase 2]
Phase 2 trial update on the safety of eplerenone in cyclosporine-treated kidney transplant recipients with chronic kidney insufficiency; cur…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients [Phase 1]
Phase 1 clinical trial evaluating the interaction between colchicine and calcineurin inhibitors in kidney transplant recipients has been com…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients [Phase 2]
Phase 2 clinical trial of a JAK3 inhibitor to prevent acute rejection in kidney transplant patients; the study has completed and results wer…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients [Phase 2]
A Phase 2 trial compared CP-690,550 (tofacitinib) with tacrolimus in kidney transplant patients, with results posted after completion in 201…